Switch to
More onapp

How to use scorecard? Learn more

Oxygenta Pharmaceutical Ltd

OXYGENTAPH
0
SmallcapWith a market cap of ₹259 cr, stock is ranked 2,242
High RiskStock is 4.46x as volatile as Nifty
73.102.59 (+3.67%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

0
SmallcapWith a market cap of ₹259 cr, stock is ranked 2,242
High RiskStock is 4.46x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
25,938.44
PB RatioPB Ratio
-12.89
Dividend YieldDiv. Yield
Sector PESector PE
7.11
Sector PBSector PB
0.19
Sector Div YldSctr Div Yld
20.76%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

0

Financial TrendFinancial statements 

202120222023202454.3161.8831.1339.742.94-0.61-11.57-3.48
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 23.56%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnNov 15, 2024

Oxygenta Pharmaceutical Ltd - 524636 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

Oxygenta Pharmaceutical Ltd - 524636 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

Result 
Announced OnNov 14, 2024

Oxygenta Pharmaceutical Ltd - 524636 - Un Audited Results For Quarter Ended On September 30, 2024 | Download

Oxygenta Pharmaceutical Ltd - 524636 - Un Audited Results For Quarter Ended On September 30, 2024 | Download

Board Meeting 
Announced OnNov 7, 2024

Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations, 2015 And All Other Applicable Regulations. | Download

Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations, 2015 And All Other Applicable Regulations. | Download

See all events